Genetic associations with sporadic neuroendocrine tumor risk

Carcinogenesis

Volumn 32, Issue 8, 2011, Pages 1216-1222

  Ter Minassian, Monica ^a,b   Wang, Zhaoxi ^a   Asomaning, Kofi ^a   Wu, Michael C ^a   Liu, Chen Yu ^a   Paulus, Jessica K ^a   Liu, Geoffrey ^c   Bradbury, Penelope A ^c   Zhai, Rihong ^a   Su, Li ^a   Frauenhoffer, Christine S ^b   Hooshmand, Susanne M ^b   de Vivo, Immaculata ^a   Lin, Xihong ^a   Christiani, David C ^a,d   Kulke, Matthew H ^b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c PRINCESS MARGARET HOSPITAL   (Canada)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEFENDER AGAINST CELL DEATH 1 PROTEIN; INTERLEUKIN 12P35; PROTEIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; APOPTOSIS; ARTICLE; CANCER RISK; CONTROLLED STUDY; FEMALE; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROENDOCRINE TUMOR; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 79961183367     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgr095     Document Type: Article

References (42)

1. Yao,J.C. et al. (2008) One hundred years after "carcinoid": epidemiologyof and prognostic factors for neuroendocrine tumors in 35,825 cases in theUnited States. J. Clin. Oncol., 26, 3063-3072.
2. Ferolla,P. et al. (2007) Epidemiology of non-gastroenteropancreatic (neuro)endocrine tumours. Clin. Endocrinol. (Oxf), 66, 1-6.
3. Kaerlev,L. et al. (2002) The importance of smoking and medical history for development of small bowel carcinoid tumor: a European population-based case-control study. Cancer Causes Control, 13, 27-34.
4. Hassan,M.M. et al. (2008) Risk factors associated with neuroendocrine tumors: a U.S.-based case-control study. Int. J. Cancer, 123, 867-873.
5. Anlauf,M. et al. (2007) Hereditary neuroendocrine tumors of the gastroenteropancreatic system. Virchows Arch., 451 (suppl. 1), S29-S38.
6. Toumpanakis,C.G. et al. (2008) Molecular genetics of gastroenteropancreatic neuroendocrine tumors. Am. J. Gastroenterol., 103, 729-732.
7. Hiripi,E. et al. (2009) Familial gastrointestinal carcinoid tumours and associated cancers. Ann. Oncol., 20, 950-954.
8. Jarhult,J. et al. (2010) First report on metastasizing small bowel carcinoids in first-degree relatives in three generations. Neuroendocrinology, 91, 318-323.
9. Hassan,M.M. et al. (2008) Family history of cancer and associated risk of developing neuroendocrine tumors: a case-control study. Cancer Epidemiol. Biomarkers Prev., 17, 959-965.
10. Garcia-Closas,M. et al. (2007) Large-scale evaluation of candidate genes identifies associations between VEGF polymorphisms and bladder cancer risk. PLoS Genet., 3, e29.
11. Pharoah,P.D. et al. (2007) Association between common variation in 120 candidate genes and breast cancer risk. PLoS Genet., 3, e42.
12. Hazra,A. et al. (2008) Large-scale evaluation of genetic variants in candidate genes for colorectal cancer risk in the Nurses' Health Study and the Health Professionals' Follow-up Study. Cancer Epidemiol. Biomarkers Prev., 17, 311-319.
13. Hosgood, H.D. III et al. (2008) Pathway-based evaluation of 380 candidate genes and lung cancer susceptibility suggests the importance of the cell cycle pathway. Carcinogenesis, 29, 1938-1943.
14. Ferris,B.G. (1978) Epidemiology Standardization Project (American Thoracic Society). Am. Rev. Respir. Dis., 118, 1-120.
15. Zhou,W. et al. (2005) Gene-smoking interaction associations for the ERCC1 polymorphisms in the risk of lung cancer. Cancer Epidemiol. Biomarkers Prev., 14, 491-496.
16. Miller,D.P. et al. (2002) Combinations of the variant genotypes of GSTP1, GSTM1, and p53 are associated with an increased lung cancer risk. Cancer Res., 62, 2819-2823.
17. Illumina Inc. (2005) GoldenGate Genotyping Assay Design Tool. Illumina Inc., San Diego, CA http://www.illumina.com/documents/products/technotes/technote_goldengate_design.pdf. (September 2008, date last accessed).
18. The International HapMap Consortium. (2005) A haplotype map of the human genome. Nature, 437, 1299-1320.
19. Benjamini,Y. et al. (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser. B, 57, 289-300.
20. Tyrer,J. et al. (2006) The admixture maximum likelihood test: a novel experiment-wise test of association between disease and multiple SNPs. Genet. Epidemiol., 30, 636-643.
21. Maggard,M.A. et al. (2004) Updated population-based review of carcinoid tumors. Ann. Surg., 240, 117-122.
22. Berkovic,M. et al. (2006) TNF-alpha promoter single nucleotide polymorphisms in gastroenteropancreatic neuroendocrine tumors. Neuroendocrinology, 84, 346-352.
23. Berkovic,M.C. et al. (2007) IL-6-174 C/G polymorphism in the gastroenteropancreatic. neuroendocrine tumors (GEP-NETs). Exp. Mol. Pathol., 83, 474-479.
24. Berkovic,M.C. et al. (2010) IL-2-330 T/G SNP and serum values-potential new tumor markers in neuroendocrine tumors of the gastrointestinal tract and pancreas (GEP-NETs). J. Mol. Med., 88, 423-429.
25. Yuan,H.Y. et al. (2006) FASTSNP: an always up-to-date and extendable service for SNP function analysis and prioritization. Nucleic Acids Res., 34, W635-W641.
26. FastSNP Database. (2006) Institute of Biomedical Sciences and Institute of Information Science. Academia Sinica: Taipei, Taiwan http://fastsnp.ibms.sinica.edu.tw/pages/input_CandidateGeneSearch.jsp. (September 2008, date last accessed).
27. Chen,X. et al. (2009) Interactions of IL-12A and IL-12B polymorphisms on the risk of cervical cancer in Chinese women. Clin. Cancer Res., 15, 400-405.
28. Lee,K.M. et al. (2007) Polymorphisms in immunoregulatory genes, smoky coal exposure and lung cancer risk in XuanWei, China. Carcinogenesis, 28, 1437-1441.
29. Navaglia,F. et al. (2005) Interleukin 12 gene polymorphisms enhance gastric cancer risk in H pylori infected individuals. J. Med. Genet., 42, 503-510.
30. Butterbach,K. et al. (2011) Association of JAK-STAT pathway related genes with lymphoma risk: results of a European case-control study (Epi-Lymph). Br. J. Haematol, 153, 318-333.
31. Lan,Q. et al. (2011) Genetic variation in Th1/Th2 pathway genes and risk of non-Hodgkin lymphoma: a pooled analysis of three population-based case-control studies. Br. J. Haematol, 153, 341-350.
32. Chang,J.S. et al. (2010) Genetic polymorphisms in adaptive immunity genes and childhood acute lymphoblastic leukemia. Cancer Epidemiol. Biomarkers Prev., 19, 2152-2163.
33. Liu,X. et al. (2010) Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis. Nat. Genet., 42, 658-660.
34. Hunt,K.A. et al. (2008) Newly identified genetic risk variants for celiac disease related to the immune response. Nat. Genet., 40, 395-402.
35. Zhernakova,A. et al. (2010) Evolutionary and functional analysis of celiac risk loci reveals SH2B3 as a protective factor against bacterial infection. Am. J. Hum. Genet., 86, 970-977.
36. International Multiple Sclerosis Genetics Consortium (IMSGC). (2010) IL12A, MPHOSPH9/CDK2AP1 and RGS1 are novel multiple sclerosis susceptibility loci. Genes Immun., 11, 397-405.
37. Del Vecchio,M. et al. (2007) Interleukin-12: biological properties and clinical application. Clin. Cancer Res., 13, 4677-4685.
38. Duda,D.G. et al. (2000) Direct in vitro evidence and in vivo analysis of the antiangiogenesis effects of interleukin 12. Cancer Res., 60, 1111-1116.
39. Ortiz,B.D. et al. (2001) Function and factor interactions of a locus control region element in the mouse T cell receptor-alpha/Dad1 gene locus. J. Immunol., 167, 3836-3845.
40. Sanjay,A. et al. (1998) DAD1 is required for the function and the structural integrity of the oligosaccharyltransferase complex. J. Biol. Chem., 273, 26094-26099.
41. Kulke,M.H. et al. (2008) High-resolution analysis of genetic alterations in small bowel carcinoid tumors reveals areas of recurrent amplification and loss. Genes Chromosomes Cancer, 47, 591-603.
42. Andersson,E. et al. (2009) High-resolution genomic profiling reveals gain of chromosome 14 as a predictor of poor outcome in ileal carcinoids. Endocr. Relat. Cancer, 16, 953-966.